Taken together, we suggest that knockdown of TM4SF4 or OPN significantly may inhibit the self-renewal properties of NSCLC cells and thus TM4SF4 and OPN may be promising targets for CSC therapy. The gene discussed is TM4SF4; the disease is non-small cell lung carcinoma.